News

Diazyme Laboratories, Inc. Announces CE-IVD for its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody Test

Tue, March 30, 2021
Diazyme Laboratories, Inc. Receives Reissued EUA for Semi-Quantitative SARS-CoV-2 IgG Test

Tue, March 23, 2021
Highlighted Study: SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses

Mon, March 15, 2021
Diazyme Laboratories, Inc. Receives Second FDA EUA for COVID-19 Antibody Test

Mon, August 17, 2020

Vitamin D Testing Simplified